# Cochrane

# Trusted evidence.

# Informed decisions.

# Better health.

# Cochrane Database of Systematic Reviews

# NCT03483246 (Continued)

• Endoscopic lesions at colonoscopy (baseline) and sigmoidoscopy by UCEIS score at week 12 after FMT or sham

Starting date: 17 September 2018

Contact information: Service de Gastroentérologie et Nutrition Hôpital Saint Antoine, Paris, 75012, France

# Notes

# NCT03561532

Study name: Fecal transplantation in ulcerative colitis (FMT-CU)

Methods: RCT conducted in Finland

# Participants

# Inclusion criteria

- Ages 18–75 years with diagnosis of UC based on clinical, endoscopic, and histologic findings
- Remission based on Mayo score 0–1 and fecal calprotectin < 100 μg/g
- Availability of consecutive fecal samples for 1 year after UC diagnosis
- Availability of blood samples to study IBD-associated genetic background
- Compliance to attend ileocolonoscopy and FMT within 3–6 months after UC diagnosis and at week 52

# Exclusion criteria

- Need for antibiotic therapy within 3 months
- Use of corticosteroids, immunosuppressives, or biologics at baseline
- Use of probiotics
- Pregnancy

# Interventions

# Experimental arm

• Fecal suspension of healthy donor feces; administered into cecum via colonoscopy

# Control arm

• Fecal suspension of autologous feces; administered into cecum via colonoscopy

# Outcomes

# Primary outcome

• Maintenance of remission of UC at 52 weeks (endoscopic remission and Mayo score < 2)

Starting date:

Contact information:

Notes:

# NCT03582969

Study name: Capsulized fecal microbiota transplantation in pediatric ulcerative colitis patients (FMT UC)

Methods: RCT conducted in Israel

# Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.